CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Spark, Pfizer's Gene Therapy Hemophilia B Drug Stuns in Trial December 6, 2017 A First: Novartis AG Drug May Prevent Heart Attacks and Cut Lung Cancer Risk Too August 27, 2017 Oncolytics Biotech Announces 2017 First Quarter Results May 4, 2017